New Federal Contractors — July 20, 2026

Leidos Biomedical Research Inc. received a $4.81B contract from HHS, representing 92.6% of total digest value. This is a high-materiality, bullish signal for Leidos, though the 2008 award date and missing pricing/competition data require caution.

Cardinal Intellectual Property Inc. won a $191.9M firm-fixed-price contract from USPTO for Patent Cooperation Treaty services over 13 years, but $0 has been outlayed, indicating the contract may not yet be active or revenue is deferred.

OptumServe Health Services, a UnitedHealth Group subsidiary, executed $175.7M of its $190M VA disability exam contract, indicating strong cash flow realization but no remaining option periods, signaling near-term completion.

Leidos Biomedical Research Inc.'s $4.81B HHS contract lacks pricing type, competition details, and annual revenue estimates, creating uncertainty about margin profile and revenue recognition timing.

Cardinal Intellectual Property Inc.'s $191.9M USPTO contract has $0 outlayed despite a 2012 start date, suggesting potential delays or non-activation, which could impair expected revenue.

The digest is heavily concentrated in a single Leidos Biomedical contract ($4.81B), making the overall signal dependent on that award's performance and transparency.

Leidos Biomedical Research Inc.'s $4.81B HHS contract underscores civilian agency spending as a growth vector for Leidos, diversifying beyond its traditional defense base.

OptumServe's $190M VA contract execution at 92.4% outlay demonstrates strong demand for veteran disability exams, suggesting UnitedHealth Group could win follow-on contracts in other VA regions.

The digest's $5.2B total is entirely civilian, with HHS ($4.81B) and VA ($190M) leading. This contrasts with typical defense-heavy procurement news, highlighting civilian agencies as a material revenue source for large contractors like Leidos and UnitedHealth.

Cardinal Intellectual Property's $191.9M contract with $0 outlay despite a 2012 start date illustrates the risk of delayed revenue recognition in multi-year civilian contracts, potentially inflating reported backlog without cash flow.

{"entity"=>"Leidos Holdings Inc.", "reason"=>"Leidos Biomedical Research Inc.'s $4.81B HHS contract is the digest's largest award but lacks critical details on pricing and competition, making it a key watch item for revenue and margin clarity.", "trigger"=>"Leidos quarterly earnings call or 10-K filing disclosing contract specifics"}

{"entity"=>"Cardinal Intellectual Property Inc.", "reason"=>"The $191.9M USPTO contract has $0 outlayed, raising questions about activation and revenue recognition; any update on outlays would be material.", "trigger"=>"USPTO procurement data update or Cardinal financial filing showing contract revenue"}

{"entity"=>"UnitedHealth Group Inc.", "reason"=>"OptumServe's $190M VA contract is nearly complete; watch for new VA solicitations in the Southeast region to assess recompetition risk.", "trigger"=>"VA solicitation for Region 2 disability examinations"}